OSEM Trademark

Trademark Overview

On Tuesday, June 9, 2026, a trademark application was filed for OSEM with the United States Patent and Trademark Office. The USPTO has given the OSEM trademark a serial number of 99874357. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 9, 2026. This trademark is owned by Uncancer, L.L.C.. The OSEM trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Services related to helping health plans and pharma partners identify high-risk oncology patients early, intervene at home, and measure outcomes directly in claims data
osem

General Information

Serial Number99874357
Word MarkOSEM
Filing DateTuesday, June 9, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, June 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesServices related to helping health plans and pharma partners identify high-risk oncology patients early, intervene at home, and measure outcomes directly in claims data

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 9, 2026
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUncancer, L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressClearwater, FL 33765
US

Trademark Events

Event DateEvent Description
Tuesday, June 9, 2026NEW APPLICATION ENTERED
Tuesday, June 9, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

osem intervene early patients measure outcomes data claims directly oncology risk